The Coming Crash in Biotech Stocks
With Profits Down By 52 Percent, Pfizer (PFE) Investors May Pressure for an M&A, a Breakup, or Both
EXCLUSIVE: Novartis AG (NVS), Amgen (AMGN) and Pfizer (PFE)’s Push Into Early Stages Exciting, But “Secret Sauce” Is Crucial, Says VC
Spurred by Biotech's Rapid Growth, Banking Giant Taps First-Ever Boston Staffer to Focus on Supercluster
AstraZeneca PLC (AZN) Rumored to be Stalking Massachusetts's Ariad Pharmaceuticals, Inc. (ARIA)
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market
Pfizer (PFE) Strikes $400 Million Deal to Avert Investor Class Action Trial
Google Inc. (GOOG) Forays Deeper Into Healthcare By Partnering Up With Biogen Idec (BIIB)
Amgen (AMGN) Submits Applications for Cancer Drug Kyprolis in U.S. and Europe
Duke University Expands; Partners Up With Google Inc. (GOOG) to Study What Makes a Healthy Human
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK)
Merck & Co. (MRK)'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge
BioMarin (BMRN) Rewrites Playbook for How Rare Disease Drugs Are Approved
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK)
Hidden Spy Camera Discovered in Johnson & Johnson (JNJ) Bathroom, Say Police
Former Novartis AG (NVS) Campus, Disused Roche (RHHBY) Medical R&D Facility Site in Talks to Become Universities
Pfizer (PFE)'s $33 Billion Cash Pile Has Everyone Speculating
Prominent Duke University Cardiologist Named Deputy Commissioner of the FDA
See All News >
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK)
Merck & Co. (MRK)'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge
BioMarin (BMRN) Rewrites Playbook for How Rare Disease Drugs Are Approved
Hidden Spy Camera Discovered in Johnson & Johnson (JNJ) Bathroom, Say Police
Former Novartis AG (NVS) Campus, Disused Roche (RHHBY) Medical R&D Facility Site in Talks to Become Universities
Pfizer (PFE)'s $33 Billion Cash Pile Has Everyone Speculating
Prominent Duke University Cardiologist Named Deputy Commissioner of the FDA
Common OTC Drugs Linked to Dementia, Alzheimer's, Group Health And University of Washington Study
Why The Super-Successful Get Depressed
Actavis (ACT)' Buying Spree Continues With $460 Million Deal
The Most Dangerous Sex Position For Men, Advances In Urology Reveals
FDA Backs Teva Pharmaceutical Industries Limited (TEVA)'s Generic Nexium in Blow to AstraZeneca PLC (AZN), Ranbaxy Laboratories (RANBAXY.BO)
Regeneron (REGN)-Sanofi (SAN.PA) Gain Edge On Amgen (AMGN) as Cholesterol Drug Snags FDA Priority Review
Shire (SHPGY)'s $5.2 Billion Bet Pays Off as NPS Pharmaceuticals, Inc. (NPSP)'s Natpara Wins Approval
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China
Thousands Sign Petition Against AstraZeneca PLC (AZN)'s Plans for Animal R&D Lab in Cambridge
MSF Not Impressed With Pfizer (PFE)'s "Tiny" Vaccine Price Cut
Merck & Co. (MRK) to Stop Selling Once-Hot Hep C Drug Victrelis
See All News >
//-->